These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27188963)

  • 1. Escherichia coli bacteraemias in intensive care unit patients.
    Wujtewicz MA; Śledzińska A; Owczuk R; Wujtewicz M
    Anaesthesiol Intensive Ther; 2016; 48(3):171-4. PubMed ID: 27188963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.
    Blandy O; Honeyford K; Gharbi M; Thomas A; Ramzan F; Ellington MJ; Hope R; Holmes AH; Johnson AP; Aylin P; Woodford N; Sriskandan S
    J Hosp Infect; 2019 Feb; 101(2):120-128. PubMed ID: 30403958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi.
    Prin M; Onofrey L; Purcell L; Kadyaudzu C; Charles A
    Am J Trop Med Hyg; 2020 Jul; 103(1):472-479. PubMed ID: 32342843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
    Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
    Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
    Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy to reduce
    Hsu D; Melzer M
    Postgrad Med J; 2018 Apr; 94(1110):212-215. PubMed ID: 29463684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia.
    Coello R; Charlett A; Ward V; Wilson J; Pearson A; Sedgwick J; Borriello P
    J Hosp Infect; 2003 Jan; 53(1):46-57. PubMed ID: 12495685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study.
    Maldonado N; López-Hernández I; López-Cortés LE; Martínez Pérez-Crespo PM; Retamar-Gentil P; García-Montaner A; De la Rosa Riestra S; Sousa-Domínguez A; Goikoetxea J; Pulido-Navazo Á; Del Valle Ortíz M; Natera-Kindelán C; Jover-Sáenz A; Arco-Jiménez AD; Armiñanzas-Castillo C; Aller-García AI; Fernández-Suárez J; Marrodán-Ciordia T; Boix-Palop L; Smithson-Amat A; Reguera-Iglesias JM; Galán-Sánchez F; Bahamonde A; Sánchez-Calvo JM; Gea-Lázaro I; Pérez-Camacho I; Reyes-Bertos A; Becerril-Carral B; Pascual Á; Rodríguez-Baño J;
    Clin Microbiol Infect; 2024 Aug; 30(8):1035-1041. PubMed ID: 38599464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort.
    Shaw E; Benito N; Rodríguez-Baño J; Padilla B; Pintado V; Calbo E; Pallarés MA; Gozalo M; Ruiz-Garbajosa P; Horcajada JP;
    J Infect; 2015 Mar; 70(3):247-54. PubMed ID: 25305497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe sepsis and septic shock by Escherichia coli, clinical and microbiological analysis in Medellin, Colombia].
    Restrepo-Álvarez CA; Bernal E; Ascuntar-Tello J; Jaimes F
    Rev Chilena Infectol; 2019 Aug; 36(4):447-454. PubMed ID: 31859768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteraemia and fungaemia in an Australian general hospital--associations and outcomes.
    McGregor AR; Collignon PJ
    Med J Aust; 1993 May; 158(10):671-4. PubMed ID: 8487685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one-year survey of nosocomial bacteraemia at a Danish university hospital.
    Eliasen K; Nielsen PB; Espersen F
    J Hyg (Lond); 1986 Dec; 97(3):471-8. PubMed ID: 3540113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying hospital-onset Escherichia coli bacteraemia cases from English mandatory surveillance: the case for applying a two-day post-admission rule.
    Davies J; Johnson AP; Hope R
    J Hosp Infect; 2017 Nov; 97(3):207-211. PubMed ID: 28687185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
    Andersen NF; Møller J; Peterslund NA
    Scand J Infect Dis; 2005; 37(2):90-5. PubMed ID: 15764199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.